Akzo Nobel N.V.

ENXTAM:AKZA Stock Report

Market Cap: €9.6b

Akzo Nobel Management

Management criteria checks 2/4

Akzo Nobel's CEO is Greg Poux-Guillaume, appointed in Nov 2022, has a tenure of 2.08 years. total yearly compensation is €4.93M, comprised of 24.8% salary and 75.2% bonuses, including company stock and options. directly owns 0.004% of the company’s shares, worth €401.05K. The average tenure of the management team and the board of directors is 4.7 years and 2.7 years respectively.

Key information

Greg Poux-Guillaume

Chief executive officer

€4.9m

Total compensation

CEO salary percentage24.8%
CEO tenure2.1yrs
CEO ownership0.004%
Management average tenure4.7yrs
Board average tenure2.7yrs

Recent management updates

Recent updates

Why Akzo Nobel N.V. (AMS:AKZA) Could Be Worth Watching

Nov 25
Why Akzo Nobel N.V. (AMS:AKZA) Could Be Worth Watching

Is Akzo Nobel (AMS:AKZA) A Risky Investment?

Oct 14
Is Akzo Nobel (AMS:AKZA) A Risky Investment?

Why We're Not Concerned About Akzo Nobel N.V.'s (AMS:AKZA) Share Price

Oct 01
Why We're Not Concerned About Akzo Nobel N.V.'s (AMS:AKZA) Share Price

Akzo Nobel's (AMS:AKZA) Returns On Capital Are Heading Higher

Sep 17
Akzo Nobel's (AMS:AKZA) Returns On Capital Are Heading Higher

What Is Akzo Nobel N.V.'s (AMS:AKZA) Share Price Doing?

Aug 21
What Is Akzo Nobel N.V.'s (AMS:AKZA) Share Price Doing?

Akzo Nobel N.V. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jul 26
Akzo Nobel N.V. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt

Jul 03
We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt

Akzo Nobel N.V. (AMS:AKZA) Shares Could Be 28% Below Their Intrinsic Value Estimate

Jun 20
Akzo Nobel N.V. (AMS:AKZA) Shares Could Be 28% Below Their Intrinsic Value Estimate

Akzo Nobel (AMS:AKZA) Is Doing The Right Things To Multiply Its Share Price

Jun 06
Akzo Nobel (AMS:AKZA) Is Doing The Right Things To Multiply Its Share Price

Market Cool On Akzo Nobel N.V.'s (AMS:AKZA) Earnings

May 10
Market Cool On Akzo Nobel N.V.'s (AMS:AKZA) Earnings

Should You Investigate Akzo Nobel N.V. (AMS:AKZA) At €66.58?

Mar 25
Should You Investigate Akzo Nobel N.V. (AMS:AKZA) At €66.58?

We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt

Mar 10
We Think Akzo Nobel (AMS:AKZA) Can Stay On Top Of Its Debt

Akzo Nobel (AMS:AKZA) Is Doing The Right Things To Multiply Its Share Price

Feb 23
Akzo Nobel (AMS:AKZA) Is Doing The Right Things To Multiply Its Share Price

Is There An Opportunity With Akzo Nobel N.V.'s (AMS:AKZA) 44% Undervaluation?

Jan 24
Is There An Opportunity With Akzo Nobel N.V.'s (AMS:AKZA) 44% Undervaluation?

CEO Compensation Analysis

How has Greg Poux-Guillaume's remuneration changed compared to Akzo Nobel's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

€565m

Jun 30 2024n/an/a

€592m

Mar 31 2024n/an/a

€534m

Dec 31 2023€5m€1m

€447m

Sep 30 2023n/an/a

€411m

Jun 30 2023n/an/a

€309m

Mar 31 2023n/an/a

€303m

Dec 31 2022€2m€204k

€362m

Compensation vs Market: Greg's total compensation ($USD5.14M) is about average for companies of similar size in the Dutch market ($USD4.27M).

Compensation vs Earnings: Greg's compensation has increased by more than 20% in the past year.

CEO

Greg Poux-Guillaume (54 yo)

2.1yrs

Tenure

€4,934,990

Compensation

Mr. Grégoire Poux-Guillaume, also known as Greg, was Chairman of the Board at medmix AG since September 20, 2021 and continues to served as its Director since 2024. He had been the Chief Executive Officer...

Leadership Team

NamePositionTenureCompensationOwnership
Grégoire Poux-Guillaume
CEO & Chairman of the Management Board2.1yrs€4.93m0.0042%
€ 401.0k
Maarten de Vries
CFO & Member of Management Board6.9yrs€2.77m0.014%
€ 1.3m
Roger Jakeman
Chief Technology Officerno datano datano data
Kyung Chae
Head Of Investor Relationsno datano datano data
Charlotte Meer
General Counselless than a yearno datano data
Leslie McGibbon
Global Head of Communications & Public Affairs and Corporate Director9.5yrsno datano data
Armand Sohet
Chief Human Resources Officer1.4yrsno datano data
Renier Vree
Chief Financial Officer of Specialty Chemicals Business6.8yrsno datano data
Charles Shaver
CEO of Specialty Chemicals6.2yrsno datano data
Karen-Marie Katholm
Chief Integrated Supply Chain Officer3.3yrsno datano data
Wiebe Wiechers
Chief Development Officerless than a yearno datano data
G. Gramser
Group Treasurer8.9yrsno datano data

4.7yrs

Average Tenure

58yo

Average Age

Experienced Management: AKZA's management team is considered experienced (4.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ben Noteboom
Independent Supervisory Board Chairman1.7yrs€109.29k0.0014%
€ 129.5k
Byron Grote
Independent Deputy Chairman of the Supervisory Board10.7yrs€133.00k0.0019%
€ 185.2k
Patrick Thomas
Independent Member of the Supervisory Board7.1yrs€112.50kno data
Hans Van Bylen
Independent Member of Supervisory Board2.7yrs€107.50kno data
Dirk Sluimers
Independent Member of the Supervisory Board9.9yrs€100.00kno data
Wouter Kolk
Member of Supervisory Boardless than a yearno datano data
Jaska de Bakker
Member of Supervisory Boardless than a yearno datano data
Ute Wolf
Member of the Supervisory Boardless than a yearno datano data
Ester Baiget
Independent Member of Supervisory Board2.7yrs€110.00kno data

2.7yrs

Average Tenure

63yo

Average Age

Experienced Board: AKZA's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 19:18
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Akzo Nobel N.V. is covered by 58 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mutlu GundoganABN AMRO Bank N.V.
Martin SchneeAlphaValue
Colin IsaacAtlantic Equities LLP